January 16, 2019 09:42 pm | Updated 09:42 pm IST - HYDERABAD
A formulations unit of pharma major Dr. Reddy’s Laboratories in Andhra Pradesh has been issued a Form 483 with four observations, following an inspection by the USFDA, the firm said in a regulatory filing. The USFDA issues the form after an inspection, in which the investigators observe any conditions that may be in violation of the Food, Drug and Cosmetic Act and related acts.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
